🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The close homology between the central and enteric nervous systems suggests...
Status
Unknown
Location
University Hospital
Start Date
2016-10
Trial ID
NCT02841605
Treatments Being Tested
The clinical and pathological similarities between LRRK2 related parkinsoni...
Status
Terminated
Location
University Hospital
Start Date
2012-03
Trial ID
NCT01618383
Treatments Being Tested
Flare-up of ulcerative colitis (UC) is characterized by the inflammation of...
Status
Terminated
Location
CHU Saint-Etienne
Start Date
2017-10-11
Trial ID
NCT03172195
Treatments Being Tested
The aim of this project is to develop an original biomarker for Parkinson's...
Status
Completed
Location
Nantes University Hospital
Start Date
2010-11
Trial ID
NCT01353183
Treatments Being Tested
Ulcerative colitis (UC) is an inflammatory bowel disease progressing throug...
Status
Completed
Location
University Hospital of Nantes
Start Date
2014-04
Trial ID
NCT02610569
Treatments Being Tested
It is planned to enroll 80 UC patients who will require optimization of gol...
Status
Completed
Location
CHU Amiens-Picardie
Start Date
2017-11-21
Trial ID
NCT03182166
Treatments Being Tested
Haemorrhagic rectocolitis is an inflammatory bowel disease that continuousl...
Status
Completed
Location
Centre Hospitalier Departemental Vendee
Start Date
2024-10-09
Trial ID
NCT06632691
Treatments Being Tested
The aim of the study is to construct and validate an endomicroscopic score ...
Status
Unknown
Location
Hôpital Europeén Georges Pompidou
Start Date
2015-04
Trial ID
NCT02676817
Rectal cancer is a common cancer with an incidence of approximately 14,000 ...
Status
Not Yet Recruiting
Location
Centre Léon Bérard
Start Date
2026-05-01
Trial ID
NCT07499921
Treatments Being Tested
Vedolizumab (VDZ) is a monoclonal antibody that binds to the heterodimer α4...
Status
Terminated
Location
CHU Amiens
Start Date
2019-03-04
Trial ID
NCT03724929
Treatments Being Tested